Showing results (21-30 of 43) with videos related to
Sort By:
Pageof 5
Alimentary Pharmacology & Therapeutics|April 16, 2013
Meta-analysis: pegylated interferon α-2a achieves higher early virological responses than α-2b in chronic hepatitis CM Romero-Gómez, R Planas, J Ampuero, et al.Journal of Viral Hepatitis|August 20, 2005
Clinical usefulness of total hepatitis C virus core antigen quantification to monitor the response to treatment with peginterferon alpha-2a plus ribavirin*V González, E Padilla, M Diago, et al.Alimentary Pharmacology & Therapeutics|October 4, 2006
Review article: management of patients with chronic hepatitis C virus infection and "normal" alanine aminotransferase activityS Zeuzem, A Alberti, W Rosenberg, et al.Revista Espanola De Fisiologia|June 1, 1983
[Action of domperidone on dopamine-induced inhibition of gastric secretion]M Diago, J M Rodrigo, S Aliño, et al.Psychiatry Research|June 14, 2021
Social cognition and its relationship with sociodemographic, clinical, and psychosocial variables in first-episode psychosisA Casado-Ortega, R Vila-Badia, A Butjosa, et al.Journal of Viral Hepatitis|January 25, 2007
Induction doses of interferon-alpha-2a in combination with ribavirin and/or amantadine for the treatment of chronic hepatitis C in non-responders to interferon monotherapy: a randomized trialJ Salmerón, M Diago, R Andrade, et al.Journal of Hepatology|March 9, 2000
A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis BV Carreño, S Zeuzem, U Hopf, et al.Journal of Viral Hepatitis|November 6, 2013
Hepatitis C virus infection alters lipid metabolism depending on IL28B polymorphism and viral genotype and modulates gene expression in vivo and in vitroÁ Rojas, J A del Campo, M Maraver, et al.Journal of Medical Virology|July 27, 2001
Multicenter randomized study comparing initial daily induction with high dose lymphoblastoid interferon vs. standard interferon treatment for chronic hepatitis CM Diago, D Suárez, L García-Villarreal, et al.The New England Journal of Medicine|December 7, 2000
Peginterferon alfa-2a in patients with chronic hepatitis CS Zeuzem, S V Feinman, J Rasenack, et al.Pageof 5